Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
12 hedge funds and large institutions have $1.92M invested in Yield10 Bioscience, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
700% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 1
155% more capital invested
Capital invested by funds: $753K → $1.92M (+$1.17M)
140% more funds holding
Funds holding: 5 → 12 (+7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$344K |
| 2 |
CC
Cannell & Co
New York
|
+$246K |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$243K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.43K |
| 5 |
First Manhattan
New York
|
+$2.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$64K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CC
1
Cannell & Co
New York
| $724K | +$246K | +1,666 | +75% |
|
|
2
Renaissance Technologies
New York
| $435K | +$344K | +2,331 | New |
|
|
WVP
3
Worth Venture Partners
Fort Lee,
New Jersey
| $307K | +$243K | +1,647 | New |
|
4
BlackRock
New York
| $293K | – | – | – |
|
|
BC
5
Birchview Capital
Burlington,
Vermont
| $147K | – | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $6K | +$4.43K | +30 | New |
|
|
HDIM
7
Hanson & Doremus Investment Management
Burlington,
Vermont
| $2K | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $2K | +$1.77K | +12 | New |
|
|
9
First Manhattan
New York
| $2K | +$2.07K | +14 | New |
|
|
VF
10
Virtu Financial
New York
| – | -$64K | -427 | Closed |
|
11
Bank of America
Charlotte,
North Carolina
| – | +$148 | +1 | New |
|
12
Wells Fargo
San Francisco,
California
| – | +$148 | +1 | New |
|
13
Morgan Stanley
New York
| – | +$295 | +2 | New |
|
YTEN Hedge Fund Activity: Q3 2020 in Review
12 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q3 2020, worth a combined $1.92M — up 155% from $753K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new YTEN positions and 1 closed out — a net gain of 7 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $344K. The largest seller was Virtu Financial, exiting entirely with an estimated $64K sold.
- 12 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q3 2020, up from 5 in Q2 2020.
- Funds reported $1.92M of Yield10 Bioscience, Inc. Common Stock stock for Q3 2020, up 155% quarter-over-quarter.
- 8 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q3 2020 and 1 closed out, a net change of +7 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q3 2020 was Renaissance Technologies, an estimated $344K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q3 2020 was Virtu Financial, an estimated $64K sold.
Based on aggregated 13F filings for Q3 2020.